TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated at StockNews.com
StockNews.com started coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note released on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also recently weighed in on TCON. Jonestrading reissued a hold rating on shares of TRACON Pharmaceuticals in a research report […]